C. Moinpour

发表

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.

J. Crowley, K. Kelly, P. Bunn, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

C. Tangen, E. Crawford, C. Moinpour, 2004, The New England journal of medicine.

Mediators, moderators, and modulators of causal effects in clinical trials––Dynamically Modified Outcomes (DYNAMO) in health-related quality of life

Yoshio Nakamura, C. Moinpour, G. Donaldson, 2009, Quality of Life Research.

Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients

J. Fries, B. Reeve, D. Cella, 2015, Quality of Life Research.

Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cance

C. Moinpour, K. Albain, J. O’Shaughnessy, 2012, Quality of Life Research.

Title The challenge of measuring intra-individual change in fatigue during cancer treatment

R. Hays, B. Reeve, D. Cella, 2016 .

The challenge of measuring intra-individual change in fatigue during cancer treatment

R. Hays, B. Reeve, D. Cella, 2017, Quality of Life Research.

Individual Differences in Quality-of-Life Treatment Response

C. Moinpour, G. Donaldson, 2002, Medical care.

Pain Management and Quality of Life in Cancer Patients

C. Chapman, C. Moinpour, 1991 .

ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research

L. McLeod, A. Wu, P. Fayers, 2013, Quality of Life Research.

Evaluation of strategies used by family food preparers to influence healthy eating

Emily Bourcier, D. Bowen, C. Moinpour, 2003, Appetite.

Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715)

L. Minasian, C. Moinpour, J. Unger, 2018, Journal of the National Cancer Institute.

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

G. Hortobagyi, L. Minasian, C. Moinpour, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inclusion of black Americans in oncology clinical trials: the Louisiana State University Medical Center experience.

R. Holcombe, C. Moinpour, J. Jacobson, 1999, American journal of clinical oncology.

Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202)

C. Moinpour, J. Unger, L. Fehrenbacher, 2017 .

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.

D. Alberts, C. Moinpour, G. Weiss, 2004, Gynecologic oncology.

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

S. Lippman, S. Martino, C. Moinpour, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes Assessment in Cancer: Treatment for colorectal cancer: impact on health-related quality of life

C. Moinpour, D. Provenzale, 2004 .

Social networks and quality of life among female long‐term colorectal cancer survivors

Amy Trentham-Dietz, P. Remington, A. Trentham-Dietz, 2003, Cancer.

Recruiting patients with breast cancer and their families to behavioral research in the post-HIPAA period.

D. Bowen, D. Ankerst, C. Moinpour, 2007, Oncology nursing forum.

Minority recruitment in the prostate cancer prevention trial.

I. Thompson, C. Coltman, C. Moinpour, 2000, Annals of epidemiology.

Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study

C. Osborne, S. Martino, C. Geyer, 1998, Breast Cancer Research and Treatment.

Quality of life in survivors of colorectal carcinoma

N Urban, Ruth Etzioni, S. Peacock, 2000, Cancer.

Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study.

C. Moinpour, K. Albain, A. Melemed, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622

G. Hortobagyi, C. Moinpour, W. Barlow, 2016, Breast Cancer Research and Treatment.

Behavioral science research in the cooperative group setting: the Southwest Oncology Group experience.

C. Gotay, C. Moinpour, P. Ganz, 2000, Journal of the National Cancer Institute.

Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences.

I. Thompson, C. Moinpour, S. Ramsey, 2013, The journal of sexual medicine.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Michael M Lieber, J Michael Gaziano, Ian M Thompson, 2005, Journal of the National Cancer Institute.

19 Utility of the enrollment period in the Prostate Cancer Prevention Trial (PCPT)

J. Crowley, I. Thompson, P. Goodman, 1997 .

RESPONSE: Re: Association of African-American Ethnic Background With Survival in Men With Metastatic Prostate Cancer

I. Thompson, C. Tangen, E. Crawford, 2001 .

Quality of life in advanced non-small-cell lung cancer: Results of a Southwest Oncology Group randomized trial

J. Crowley, K. Kelly, P. Grevstad, 2002, Quality of Life Research.

Measuring quality of life : an emerging science. Discussion

C. Moinpour, M. Gralla, M. Coltman, 1994 .

Measuring quality of life: an emerging science.

C. Moinpour, 1994, Seminars in oncology.

Quality-of-life assessment in cancer clinical trials: a status report.

D. Cella, C. Moinpour, P. Ganz, 1992, Journal of the National Cancer Institute.

Funding patient-reported outcomes in cancer clinical trials.

E. Trimble, C. Moinpour, S. Land, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Costs of quality-of-life research in Southwest Oncology Group trials.

C. Moinpour, 1996, Journal of the National Cancer Institute. Monographs.

Correlations in perceived food use between the family food preparer and their spouses and children

D. Bowen, C. Moinpour, D. McLerran, 2003, Appetite.

Assessing meaningful change over time in quality of life: A user's guide for clinicians

D. Patrick, D. Revicki, C. Moinpour, 2002 .

Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy

D. Cella, D. Fairclough, C. Moinpour, 1999, Quality of Life Research.

Southwest Oncology Group (SWOG).

C. Moinpour, P. Feigl, L. Loll, 1996, Journal of the National Cancer Institute. Monographs.

Learning to live with missing quality-of-life data in advanced-stage disease trials.

C. Moinpour, G. Donaldson, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Patient Reported Outcomes Measurement Information System ( PROMIS ® ) Perspective on : Universally-Relevant vs . Disease-Attributed Scales

R. Hays, D. Tulsky, D. Cella, 2014 .

SWOG S1007: A phase III, randomized clinical trial of standard adjuvant endocrine therapy with or without chemotherapy in patients with one to three positive nodes, hormone receptor (HR)-positive, and HER2-negative breast cancer with recurrence score (RS) of 25 or less.

G. Hortobagyi, C. Moinpour, S. Ramsey, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life in long term survivors of colorectal cancer

C. Moinpour, S. Ramsey, M. Andersen, 2002, American Journal of Gastroenterology.

The clinical significance of quality of life assessments in oncology: a summary for clinicians

G. Guyatt, J. Sloan, D. Cella, 2006, Supportive Care in Cancer.

Predictors of vitality (energy/fatigue) in early stage Hodgkin's disease (HD): Results from Southwest Oncology Group (SWOG) Study 9133.

R. Fisher, D. Pauler, C. Moinpour, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Challenges posed by non‐random missing quality of life data in an advanced‐stage colorectal cancer clinical trial

C. Moinpour, B. McKnight, F. Muggia, 2000, Psycho-oncology.

Quality of life end points in cancer clinical trials: review and recommendations.

C. Moinpour, J. Crowley, F. Meyskens, 1989, Journal of the National Cancer Institute.

Erectile Dysfunction and Incidence of Cardiovascular Disease—Reply

I. Thompson, P. Goodman, C. Tangen, 2006 .

Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.

Donna L Berry, E. Crawford, D. Ankerst, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ensuring the quality of quality of life data: the Southwest Oncology Group experience.

C. Moinpour, L. Lovato, 1998, Statistics in Medicine.

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).

C. Moinpour, E. Crawford, O. Kucuk, 2001, Urology.

Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)

I. Thompson, P. Goodman, C. Tangen, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Erectile dysfunction and subsequent cardiovascular disease.

I. Thompson, P. Goodman, C. Tangen, 2005, JAMA.

Intermittent versus continuous androgen deprivation in prostate cancer.

Donna L Berry, Ian M Thompson, Stephen Prescott, 2013, The New England journal of medicine.

Measuring social function in diverse cancer populations: Evaluation of measurement equivalence of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Ability to Participate in Social Roles and Activities short form.

J. Teresi, D. Cella, E. Hahn, 2016, Psychological test and assessment modeling.

Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

I. Thompson, S. Lippman, C. Coltman, 2007, Journal of the National Cancer Institute.

Substituting proxy ratings for patient ratings in cancer clinical trials: An analysis based on a Southwest Oncology Group trial in patients with brain metastases

C. Moinpour, K. Chansky, C. M. Moinpour, 2000, Quality of Life Research.

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

L. Collette, M. Piccart, M. Taphoorn, 2016, The Lancet. Oncology.

Patient income level and cancer clinical trial participation.

J. Crowley, C. Moinpour, J. Unger, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of African-American ethnic background with survival in men with metastatic prostate cancer.

I. Thompson, C. Tangen, E. Crawford, 2001, Journal of the National Cancer Institute.

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.

I. Thompson, C. Tangen, N. Agarwal, 2013, The Lancet. Oncology.

Missing quality of life data in cancer clinical trials: serious problems and challenges.

D. Osoba, L. Fallowfield, D. Cella, 1998, Statistics in medicine.

Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

J. Crowley, J. Doroshow, C. Moinpour, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

I. Thompson, C. Moinpour, E. Canby-Hagino, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Physician Participation in Research Surveys

J. Bradshaw, K. Sullivan, C. Moinpour, 1999, Evaluation & the health professions.

A randomized clinical trial of home nursing care for lung cancer patients

C. Moinpour, J. Benoliel, R. McCorkle, 1989, Cancer.

Provider and partner interactions in the treatment decision‐making process for newly diagnosed localized prostate cancer

I. Thompson, C. Moinpour, S. Ramsey, 2011, BJU international.

Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research

M. Fiore, N. Rigotti, R. Herbst, 2016, Clinical Cancer Research.

The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research: Implications for Clinical Practice and Health Care Policy

Albert W Wu, Ethan Basch, Sara Ahmed, 2012, Medical care.

United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer.

B. Reeve, D. Cella, E. Hahn, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Responsiveness of 8 Patient‐Reported Outcomes Measurement Information System (PROMIS) measures in a large, community‐based cancer study cohort

R. Hays, D. Cella, E. Hahn, 2017, Cancer.

Assessing meaningful change in quality of life over time: a users' guide for clinicians.

D. Patrick, D. Revicki, C. Moinpour, 2002, Mayo Clinic proceedings.

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.

C. Moinpour, J. Unger, L. Fehrenbacher, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.

S. Lippman, P. Philip, C. Moinpour, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessing health-related quality of life in cancer trials

D. Fairclough, C. Moinpour, Roxanne E. Jensen, 2012 .

Osteonecrosis of the jaw in patients with cancer receiving zoledronic acid for bone metastases: SWOG S0702, NCT00874211.

C. Moinpour, J. Unger, J. Gralow, 2019, Journal of Clinical Oncology.

A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

C. Gotay, C. Moinpour, A. Wozniak, 2012, The oncologist.

The Measuring Your Health Study: Leveraging Community-Based Cancer Registry Recruitment to Establish a Large, Diverse Cohort of Cancer Survivors for Analyses of Measurement Equivalence and Validity of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Short Form Items

C. Moinpour, R. Cress, A. Potosky, 2016 .

Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials

D. Cella, C. Moinpour, P. Ganz, 1992, Quality of Life Research.

Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

J. Crowley, K. Kelly, C. Presant, 2002, Journal of the National Cancer Institute.

Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.

E. Crawford, A. Troxel, C. Moinpour, 1998, Journal of the National Cancer Institute.

Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.

L. Minasian, C. Moinpour, J. Unger, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer.

C. Moinpour, J. Unger, J. Gralow, 2020, JAMA oncology.

Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence.

S. Lippman, S. Martino, C. Gotay, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

C. Moinpour, M. Lacouture, A. Barzi, 2020, Journal of Patient-Reported Outcomes.

Using a Population-Based Cancer Registry for Recruitment of Newly Diagnosed Patients With Ovarian Cancer

Nicole Urban, C. Moinpour, N. Urban, 2005, American journal of clinical oncology.

An Educational Program to Increase Cervical and Breast Cancer Screening in Hispanic Women: A Southwest Oncology Group Study

D. Pauler, C. Moinpour, F. Meyskens, 2005, Cancer nursing.

A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): Does format affect patient ratings of symptoms and quality of life?

M. Kris, C. Moinpour, R. Gralla, 2005, Quality of Life Research.

Quality of life in long term survivors of colorectal cancer.

C. Moinpour, S. Ramsey, M. Andersen, 2002 .

P. Remington, A. Trentham-Dietz, P. Newcomb, 2003, The oncologist.

Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.

B. Reeve, D. Cella, N. Aaronson, 2014, Urologic oncology.

Measurement Properties of PROMIS Sleep Disturbance Short Forms in a Large, Ethnically Diverse Cancer Cohort

J. Teresi, B. Reeve, C. Moinpour, 2016 .

Do general dimensions of quality of life add clinical value to symptom data?

C. Moinpour, G. Donaldson, M. Redman, 2007, Journal of the National Cancer Institute. Monographs.

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

I. Thompson, C. Tangen, C. Moinpour, 2018, Journal of Patient-Reported Outcomes.

I. Thompson, C. Tangen, C. Moinpour, 2018 .

Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events.

Shing M. Lee, C. Moinpour, J. Unger, 2016, Journal of oncology practice.

Quality of Life Assessment in Southwest Oncology Group Clinical Trials: Translating and Validating a Spanish Questionnaire

C. Moinpour, 1994 .

Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.

S. Martino, C. Moinpour, P. Ganz, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

L. Collette, M. Piccart, M. Taphoorn, 2018, Clinical trials.

SWOG S0715: Randomized placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy during adjuvant breast cancer therapy.

G. Hortobagyi, L. Minasian, C. Moinpour, 2012 .

Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin’s disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208

M. Kaminski, R. Fisher, C. Moinpour, 2017, Journal of Cancer Survivorship.

Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.

R. Fisher, D. Pauler, C. Moinpour, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Health S tatus a nd Q uality o f L ife i n P atients W ith Early-Stage H odgkin's D isease T reated o n S outhwest O ncology Group S tudy 9 133

R. Fisher, D. Pauler, C. Moinpour, 2003 .

Enhancing nurse contributions to SWOG clinical trials.

C. Moinpour, L. Hansen, Rose B Ermete, 2014, Seminars in oncology nursing.

I. Thompson, Christine Johnson, D. Patrick, 2012, Journal of the National Cancer Institute.

Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors.

I. Thompson, C. Coltman, D. Patrick, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trial.

C. Moinpour, C. Osborne, S. Green, 1993, Oncology nursing forum.

Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants.

C. Moinpour, B. Bruemmer, S. Aker, 2000, Journal of the American Dietetic Association.

Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis.

I. Thompson, C. Moinpour, S. Ramsey, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Pattern mixture models for longitudinal quality of life studies in advanced stage disease

D. Pauler, C. Moinpour, Carol Moinpour, 2003, Statistics in medicine.

Association between body mass index and response to duloxetine for aromatase inhibitor‐associated musculoskeletal symptoms in SWOG S1202

C. Moinpour, J. Unger, K. Crew, 2019, Cancer.

Factors associated with length of stay in hospice.

C. Moinpour, L. Polissar, D. Conrad, 1990, Medical care.

Factors affecting place of death of hospice and non-hospice cancer patients.

C. Moinpour, L. Polissar, C M Moinpour, 1989, American journal of public health.

Do quality of life assessments make a difference in the evaluation of cancer treatments?

C. Moinpour, 1997, Controlled clinical trials.

The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).

C. Gotay, J. Sloan, C. Moinpour, 2015, Journal of pain and symptom management.

Data Pooling and Analysis to Build a Preliminary Item Bank

B. Reeve, D. Cella, J. Lai, 2005, Evaluation & the health professions.

Vascular Endothelial Growth Factor Polymorphisms in Early-Stage Non- Small-Cell Lung Cancer

C. Moinpour, P. Ganz, J. Unger, 2008 .

Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702

C. Moinpour, J. Unger, J. Gralow, 2017, Supportive Care in Cancer.

Omega-3 fatty acids for aromatase inhibitor–induced musculoskeletal symptoms in women with early-stage breast cancer (SWOG S0927).

L. Minasian, C. Moinpour, J. Unger, 2014 .

Strengthened estimates of individual pain trends in children following bone marrow transplantation

C. Moinpour, G. Donaldson, 1992, Pain.

Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population

I. Thompson, C. Moinpour, S. Ramsey, 2011, International journal of general medicine.

Preliminary treatment considerations among men with newly diagnosed prostate cancer.

I. Thompson, C. Moinpour, S. Ramsey, 2010, The American journal of managed care.

Quality of life assessment in Southwest Oncology Group trials.

I. Thompson, C. Moinpour, P. Feigl, 1990, Oncology.

Burden among partner caregivers of patients diagnosed with localized prostate cancer within 1 year after diagnosis: an economic perspective

I. Thompson, C. Moinpour, S. Ramsey, 2013, Supportive Care in Cancer.

OT1-03-01: A Randomized Phase III Clinical Trial of Standard Adjuvant Endocrine Therapy +/− Chemotherapy in Patients (pts) with 1–3 Positive Nodes, Hormone Receptor (HR)-Positive and HER2−Negative Breast Cancer with Recurrence Score (RS) of 25 or Less: SWOG S1007.

C. Moinpour, S. Ramsey, W. Barlow, 2011 .

A randomized clinical trial of home nursing care for lung cancer patients

C. Moinpour, J. Benoliel, R. McCorkle, 1989, Cancer.

Chemotherapeutic impact on pain and global health-related quality of life in hormone-refractory prostate cancer: Dynamically Modified Outcomes (DYNAMO) analysis of a randomized controlled trial

Yoshio Nakamura, C. Moinpour, G. Donaldson, 2009, Quality of Life Research.

The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research: Implications for Clinical Practice and Health Care Policy

A. Wu, E. Basch, B. Reeve, 2012, Medical care.

Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions

C. Moinpour, S. Ramsey, D. Penson, 2011, World Journal of Urology.

University of Birmingham Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

L. Collette, M. Piccart, M. Taphoorn, 2018 .

Outcomes Assessment in Cancer: Treatment for colorectal cancer: impact on health-related quality of life

C. Moinpour, D. Provenzale, 2004 .